GEN Exclusives

More »

GEN News Highlights

More »
Oct 6, 2009

Quidel and BioHelix Join Forces to Develop Handheld Tests for Pathogens

  • Quidel will be developing in vitro molecular diagnostic tests utilizing BioHelix’ isothermal-amplification technology. BioHelix’ expertise in the R&D of nucleic acid technologies for diagnostic applications will be combined with Quidel’s strength in the development, manufacture, and commercialization of such tests.

    Under the development and commercialization agreement, Quidel will fund and jointly develop with BioHelix assays for rapid detection of infectious pathogens in a noninstrumented, handheld format. BioHelix will have primary responsibility for assay development. Quidel will have exclusive, worldwide commercialization rights for the new products. It will also undertake all manufacturing and marketing.

    BioHelix’ IsoAmp® Molecular Analyzer is an instrument-free molecular diagnostic platform consisting of its Helicase-Dependent Amplification technology and a disposable detection device entitled the BESt™ Cassette.

     



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?